Paul Hartmann AG Logo

Paul Hartmann AG

PHH2 | F

Overview

Corporate Details

ISIN(s):
DE0007474041
LEI:
5493008OWN3GUZK1EW25
Country:
Germany
Address:
Paul-Hartmann-Straße 12, 89522 Heidenheim an der Brenz
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Paul Hartmann AG, operating as the HARTMANN GROUP, is a leading international provider of medical and hygiene products and system solutions. With a history spanning over 200 years, the company's core business is organized into three primary segments: Wound Management, Incontinence Management, and Infection Management. Its portfolio includes therapeutic bandages, first aid supplies, discreet incontinence solutions, and products for risk prevention. HARTMANN serves both medical professionals and private customers, aiming to deliver solutions that are economically beneficial and simplify care for patients and caregivers. The company also develops digital services and business models to complement its core offerings.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Paul Hartmann AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-04-25 16:46
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, buy
English 6.0 KB
2025-04-22 00:00
Annual / Quarterly Financial Statement
Ergänzung der Veröffentlichung vom 08.08.2023
German 8.6 KB
2024-11-07 00:00
Annual / Quarterly Financial Statement
Konzernabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
German 737.8 KB
2024-09-30 00:00
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
German 313.3 KB
2024-08-19 15:46
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, buy
English 7.8 KB
2024-08-13 00:00
Interim Report
Halbjahresabschluss 2024
German 232.3 KB
2024-03-19 00:00
Annual Report
Jahresabschluss 2023
German 4.1 MB
2024-02-02 17:17
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 8.5 KB
2024-02-02 17:13
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 8.5 KB
2024-02-02 17:08
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 8.0 KB
2024-02-02 17:05
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 9.3 KB
2024-02-02 17:00
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 8.0 KB
2024-02-02 16:55
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 8.9 KB
2024-02-02 16:50
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 8.5 KB
2024-02-01 19:56
Director's Dealing
PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf
German 8.0 KB

Automate Your Workflow. Get a real-time feed of all Paul Hartmann AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Paul Hartmann AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-08-19 SCHWENK Limes GmbH & Co. KG Close relation Buy None 201,400.00 EUR
2024-02-02 SCHWENK Limes GmbH & Co. KG Close relation Buy None 72,000.00 EUR
2024-02-02 SCHWENK Limes GmbH & Co. KG Close relation Buy None 71,750.00 EUR
2024-02-02 SCHWENK Limes GmbH & Co. KG Close relation Buy None 70,200.00 EUR
2024-02-02 SCHWENK Limes GmbH & Co. KG Close relation Buy None 68,472.00 EUR
2024-02-01 SCHWENK Limes GmbH & Co. KG Close relation Buy None 127,800.00 EUR
2024-02-01 SCHWENK Limes GmbH & Co. KG Close relation Buy None 70,500.00 EUR
2024-02-01 SCHWENK Limes GmbH & Co. KG Close relation Buy None 69,000.00 EUR
2024-02-01 SCHWENK Limes GmbH & Co. KG Close relation Buy None 63,280.00 EUR
2024-02-01 SCHWENK Limes GmbH & Co. KG Close relation Buy None 63,000.00 EUR

Peer Companies

Company Country Ticker View
Theradiag Logo
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
France ALTER
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
Developing disruptive spinal fixation devices for the vertebral surgery market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
Global provider of medical devices and genetic testing services for the IVF treatment journey.
Sweden VITR
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO
Ypsomed Holding AG Logo
Develops injection systems for self-medication, partnering with pharma and biotech firms.
Switzerland YPSN